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In Brief
Caveney et al. report the structure and
domain organization of LpoP and its
interaction site with PBP1B from
P. aeruginosa. They show that LpoP has
an intrinsically disordered N-terminal
extension, followed by a globular domain,
which is different from the structure of the
globular domain of E. coli LpoB. They
show that this domain specifically
interacts with the UB2H domain of
PaPBP1B..
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SUMMARY
Peptidoglycan (PG) is an essential component of the
bacterial cell wall and is assembled from a lipid II
precursor by glycosyltransferase and transpeptidase
reactions catalyzed in particular by bifunctional class
Apenicillin-bindingproteins (aPBPs). In themajor clin-
ical pathogen Pseudomonas aeruginosa, PBP1B is
anchoredwithin the cytoplasmicmembrane but regu-
latedbyabespokeoutermembrane-localized lipopro-
tein known as LpoP. Here, we report the structure of
LpoP, showing an extendedN-terminal, flexible tether
followedbyawell-orderedC-terminal tandem-tetratri-
copeptide repeat domain. We show that LpoP
stimulates both PBP1B transpeptidase and glycosyl-
transferase activities in vitro and interacts directly via
its C terminus globular domain with the central UB2H
domain of PBP1B. Contrary to the situation in E. coli,
P. aeruginosa CpoB does not regulate PBP1B/LpoP
in vitro. Wepropose amechanism that helps to under-
score similarities and differences in class A PBP acti-
vation across Gram-negative bacteria.
INTRODUCTION
The biosynthesis of the bacterial cell wall is an excellent target for
antibacterial therapy, as exemplified by the clinical action of
b-lactam antibiotics, which inhibit one of the final steps in the
pathway of peptidoglycan (PG) biosynthesis. PG is comprised
of polymerized glycan strands of alternating, b-1,4-linked N-ace-
tylglucosamine and N-acetylmuramic acid. Adjacent strands are
covalently linked by short peptides protruding from the N-acetyl-
muramic acid moieties to form an extended mesh-like macro-
molecule called the sacculus, which surrounds the cytoplasmic
membrane (Caveney et al., 2018; Typas et al., 2012). PG plays
a crucial structural role in the bacterial cell envelope, and defects
in PG typically result in cell lysis within the natural environs of the
bacteria (Caveney et al., 2018; Egan et al., 2017).
PG biosynthesis initiates in the cytoplasm and leads to pro-
duction of the membrane-localized glycopeptide precursor, lipid
II, which is flipped to the external leaflet of the cytoplasmic mem-
brane for the polymerization of glycan strands and crosslinking
of peptides by PG synthases. Class A penicillin-binding proteins
(aPBPs) are the critical and principal PG synthase for proper cell
wall assembly and cell integrity in most bacteria where they have
been investigated (Cho et al., 2016). These bifunctional enzymes
perform, in distinct active sites, both the glycosyltransferase
(GTase) activity, which polymerizes glycan strands from lipid II,
and a DD-transpeptidase (TPase) activity, which cleaves a D-
Ala4-D-Ala5 peptide bond of the acyl donor and transfers the
D-Ala4 carbonyl to the primary amine of a diaminopimelic acid
residue on the acceptor peptide. The DD-TPase activity is
blocked by b-lactam antibiotics, which irreversibly acylate the
conserved catalytic serine nucleophile (Caveney et al., 2018).
Over the last years, it became evident that the dual activities of
some class A PBPs are differentially regulated by cognate outer
membrane-anchored lipoprotein activators, LpoA (mainly
TPase) and LpoB (GTase and TPase) (Typas et al., 2010; Lupoli
et al., 2014; Egan et al., 2018). Moreover, Escherichia coli sub-
jects the LpoB-mediated stimulation of PBP1B to regulation by
CpoB, which functions together with members of the Tol system
to coordinate outer membrane constriction with septal PG syn-
thesis (Gray et al., 2015). These regulators have all been identi-
fied and characterized, at least in part, in E. coli with recent
work providing insights into their structures, interface with the
PBP, and mechanisms of PBP activation (Egan et al., 2014,
2018; Jean et al., 2014; Kelley et al., 2019; King et al., 2014; Mar-
kovski et al., 2016). These studies suggest that activators bind to
a non-catalytic docking domain (termed the UB2H domain in
PBP1B) causing conformational changes that ultimately affect
active site residues and presumably consequent catalytic turn
over (Markovski et al., 2016; Egan et al., 2018). The significant
nosocomial pathogen Pseudomonas aeruginosa also has a sug-
gested lipoprotein activator of its cognate PBP1B, termed LpoP,
which is distinct in primary sequence to the E. coli LpoB (Greene
et al., 2018). Importantly, LpoP was shown to be essential for
Pseudomonas PBP1B function in the cell, and additional prelim-
inary investigation to unravel the mechanism of activation was
performed (Greene et al., 2018), However, the structure of
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LpoP remained unknown as well as experimental demonstration
of the direct activation of PBP1B by LpoP (Greene et al., 2018).
Here, we show that LpoP shares general domain organization
with LpoB, with both having a long, intrinsically disordered N-ter-
minal region and a structured C-terminal region. Our crystal
structure of the ordered C-terminal region revealed a tandem-
tetratricopeptide repeat (tandem-TPR) structure. We probed
the role of LpoP in activating P. aeruginosa PBP1B (PaPBP1B)
and show that LpoP interacts with PaPBP1B and stimulates its
GTase and TPase activities in vitro. In addition, we show that
P. aeruginosa CpoB (PaCpoB) does not regulate PaPBP1B/
LpoP in vitro, contrary to its role in E. coli. To further dissect
the PaPBP1B-LpoP interaction, we show that the UB2H domain
of PaPBP1B interacts with the C terminus of LpoP and use NMR
to probe this interface. We propose a mechanism for the
activation of PBP1B in P. aeruginosa that helps to understand
Figure 1. LpoP Has an Intrinsically Disor-
dered N-Terminal Domain and a C-Terminal
Globular Domain
(A) Overlay of the 1H-15N heteronuclear NOE re-
corded with and without initial proton saturation.
Saturated experiment is plotted in red and green
for positive and negative contour, respectively,
whereas the reference experiment recorded
without 1H saturation is plotted in black. Both 2D
1H-15N experiments were collected on a 16.4-T
NMR spectrometer at 25C. Protein samples were
prepared at 0.2 mM in 30 mMHEPES, 200mMKCl
buffer (pH 7.5).
(B) Heteronuclear 1H-15N-NOE values calculated
from the intensity ratio between the saturated and
reference experiments. Regions with sequential
positive 1H-15N-NOE values are colored in red and
correspond to a structured domain. Errors in the
intensity ratio were calculated from the signal-to-
noise ratio of the NMR signal in each spectrum.
The numbering begins at Ala20 just after the lipo-
box (residues 16–19). High, low, and negative
1H-15N-NOE values indicate low, medium, and
high flexibility, respectively.
(C) Sequence of LpoP starting at residue Ala20 just
after the lipobox segment, colored as in (B).
similarities and differences in class A
PBP activation across Gram-negative
bacteria.
RESULTS
Structural Organization of Full-
Length LpoP
To obtain structural information for LpoP,
we used a hybrid approach involving
both NMR and crystallography. This was
required due to thepredicted combination
of both structured and intrinsically disor-
dered regions in LpoP, which could not
be probed optimally by either technique
alone. LpoP is a predicted lipoprotein of
259aminoacidswith aclear lipoboxsignal
sequence that promotes localization and attachment to the
P. aeruginosa outer membrane via an N-terminal lipid modifica-
tion at Cys19 (Greene et al., 2018). The 1H-15N correlation spec-
trum of 15N-labeled LpoP (residues 20–259 with signal sequence
removed for optimal solubility) displayed both dispersed peaks
and intense narrow peaks with a very low 1H chemical shift
dispersion, confirming the presence of structured and unstruc-
tured regions (Figure 1A). NMR data were recorded on a
[15N-13C] LpoP sample and the backbone and side chain
1H-15N-13C resonances were assigned using conventional tri-
dimensional experiments. The assigned spectra revealed that
residues Asp 154 to Ser 258 form a globular domain consisting
of a succession of six helices (as determined by chemical shift in-
dex analysis––Figure S1) (Berjanskii and Wishart, 2005). 1H-15N
nuclear Overhauser effect (NOE) relaxation measurements dis-
played positive NOE values (>0.6) for residues 154–258, in
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agreement with the presence of a globular and stable domain
(Figure 1A). With the exception of the short stretch from residues
147 to153with intermediateNOEvalues (0.15–0.4), the rest of the
residues produced low or negative NOE values, which indicated
fastmotion (Figure 1B).Hence, theperiplasmic part of LpoPcom-
prises an N-terminal intrinsically disordered domain (residues
20–146) that is connected by a short segment with reduced
mobility (residues 147–153) to the C-terminal globular domain
(residues 154–258) (Figure 1C).
Structure of the Globular C-Terminal Domain of LpoP
Crystals of P. aeruginosa LpoP143-259 displayed monoclinic P21
symmetry with unit cell dimensions of a = 48.8 A, b = 154.6 A,
c = 54.1 A, and b = 90.1, and diffracted with a resolution of
2.2 A. There are eight molecules of LpoP in the asymmetric
unit. The structure solution was phased usingmolecular replace-
ment and a homology model of LpoP143-259 and final refinement
statistics were generated (Table S1). The resulting maps showed
well-resolved electron density for most of the protein chain, al-
lowing near complete tracing of the ordered part from residues
152 onward (see the STAR Methods). The structure indicated a
monomeric form of the protein with no obvious crystallographic
formation of larger oligomers. LpoP143-259 is made up of six a he-
lices (H1–H6) of variable length that form helix-turn-helix motifs
similar to those of TPRs and that are linked together through
short loops (Figures 2A and 2B) (Cortajarena et al., 2004; Zeytuni
and Zarivach, 2012). Numerous inter-helical hydrophobic con-
tacts favored by the high percentage of Leu (12%) and Ala
(22%) stabilize the core structure (Figure S2A). LpoP has a strik-
ing structural similarity to protein domains formed by repetition
of TPR domains (prosite PS50293 family). In particular, LpoP
has a structure similar to the TPR domain of CpoB (PDB:
2XEV; Krachler et al., 2010) (root-mean-square deviation
[RMSD] = 1.2 A˚ over main chain atoms from 59 residues and
2.5 A˚ over all 100 residues, in comparison with an RMSD of
0.3 A˚ over all 104 residues among the 8 LpoP molecules in the
asymmetric unit) despite a limited sequence identity of 18% (Fig-
ure 2C) and varied electrostatic surface potential (Figure S2B).
There was no significant structural conservation observed
between LpoP and either of the activators LpoA (Vijayalakshmi
et al., 2008) and LpoB (King et al., 2014) (Figure S2C).
LpoP Interacts with PaPBP1B and Stimulates Its
Activities In Vitro
LpoP was identified as a potential PaPBP1B activator based on
the genetic observation that the presence of LpoP is required
for the function of PaPBP1B in the cell (Greene et al., 2018). We
wished to push this idea further to show that, like the E. coli
LpoB/PBP1B activator/synthase pair, a direct physical interac-
tion of LpoP with PaPBP1B is the underlying basis for activation.
To test for this interaction in vitro, we conducted surface
plasmon resonance (SPR) experiments with the purified proteins
(Figure 3A). LpoP bound to immobilized PaPBP1B with a KD of
4.2 ± 0.5 mMand approaching binding saturation at a concentra-
tion of approximately 10 mM. Monitoring the rate of GTase activ-
ity in the presence and absence of LpoP in a continuous assay
(Egan and Vollmer, 2016) revealed that LpoP stimulated the
GTase rate of PaPBP1Bby 4.5-fold (Figures 3B and S3B). In addi-
tion, an endpoint TPase activity assay showed a 2-fold increase
in transpeptidation products synthesized by PaPBP1B in the
presence of LpoP (Figures 3B and S3C).
PaCpoB Is Not a Regulator of PaPBP1B In Vitro
In an in vitro assay of PaPBP1B TPase activity, the addition of
PaCpoB to a reaction containing PaPBP1B and LpoP did not alter
crosslinking of the PG product (Figures 3B and S3C). This result
was consistent with our SPR analysis showing that PaPBP1B did
not interact with PaCpoB over the concentration range tested
(Figure 3A). This is in contrast to the interaction of E. coli CpoB
with PBP1B and its reduction of the stimulation of the TPase ac-
tivity by LpoB.
C-Terminal Globular Domain of LpoP Interacts with the
UB2H Domain of PaPBP1B
In E. coli, LpoB interacts with the regulatory UB2H domain of
PBP1B. Since a similar domain is present in PaPBPB1B (residues
66–159, 24% identity to E. coli), we used biolayer interferometry
(BLI) to test for the interaction and quantify equilibrium dissocia-
tion constants (KD) of the
PaUB2H-LpoP complex (Figure S4).
The BLI curves were subjected to kinetic analysis and a KD of
0.4 ± 0.6 mMwas determined (Figure 4A). This KD is slightly lower
than the one obtained for the full PaPBP1B by SPR (4.2 ± 0.5 mM)
but this difference could be due to the specific buffer required to
measure the KD by BLI using the truncated UB2H domain. How-
ever, the similarity between the two affinities suggests that the
complex between LpoP and PaPBP1B is largely stabilized by a
direct interaction of LpoP with the UB2H domain.
Superimposition of [1H,15N] BEST-TROSY spectra (Figure 4B)
of LpoP in the presence or absence of PAUB2H readily identified
perturbed LpoP amide resonances, and the progressive shifts
Figure 2. Structure of the Globular Domain of LpoP
(A) Structure of LpoP143-259 determined by X-ray crystallography.
(B) Schematic representation of the LpoP143-259 secondary structure.
(C) Alignment of crystal structures of P. aeruginosa LpoP143-259 (blue) and
Xanthomonas campestris CpoB3-124 (green and grey).
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observed for the different concentration suggests a rapid ex-
change regime between the two domains, in agreement with
the moderate affinity constant measured for this complex.
Chemical shift perturbation was determined for each amino
acid resonance and reported in a graph (Figure S5). The maximal
chemical shift perturbations were mapped on the LpoP structure
(Figure 4C) and found to concentrate mainly in the region con-
necting the extremities of helix 2 and helix 3. As shown in Fig-
ure 4D, this region also contains the most conserved amino
acid residues as obtained by alignment of 150 sequences using
ConSurf software.
LpoP Likely Interacts between the GTase and UB2H
Domains of PaPBP1B
We have been unable to produce a stable 15N-labeled UB2H
domain, which prevented us from performing further experi-
ments on the interface residues in PaPBP1B. Therefore, we
turned to co-evolutionary analysis of PaPBP1B and LpoP
(GREMLIN; Ovchinnikov et al., 2014). While LpoP is not widely
conserved among Gram-negative bacteria, there was a small
subset of species with both a PBP1B and LpoP homolog
(Greene et al., 2018), resulting in putative (with medium to low
confidence) interface residues in PaPBP1B (Figures 5A and 5B).
These data suggest that LpoP likely also associates with the
GTase domain of PaPBP1B, sitting between the UB2H and
GTase domains, as has been proposed for the binding site for
E. coli LpoB with EcPBP1B.
DISCUSSION
The recent identification of LpoP, which is required for the proper
function of PBP1B in Pseudomonas (Greene et al., 2018), promp-
ted thisbiochemical andbiophysical analysisofLpoP. In thiswork,
we performed an in-depth investigation via NMR spectroscopy,
biochemicalassays toprobeactivityandbinding,X-raycrystallog-
raphy, and co-evolutionary analysis. We reveal the semi-
conserved nature of class A PBP activation, highlighting the simi-
larities and differencesbetween LpoB- and LpoP-based systems.
Commonalities between LpoB- and LpoP-Based
Systems
We show that the domain organization of LpoP is consistent with
the model that it serves to activate PaPBP1B in an analogous
manner to that by which LpoB activates EcPBP1B. Using NMR,
we show that LpoP has an intrinsically disordered N-terminal
extension, followed by a structured globular domain that specif-
ically interacts with the UB2H domain of PaPBP1B. This is similar
to the previously found architecture of LpoB, which has been
proposed to activate EcPBP1B in response to the porosity of
the PG layer (Typas et al., 2010, 2012). According to this model,
LpoB activates the synthase at sites with stretched PG. Recent
work showed that EcPBP1B/LpoB also forms a PG repair com-
plex with the LD-transpeptidase LdtD and the DD-carboxypep-
tidase PBP6A, which was hypothesized to repair faults in PG
that arise upon severe outer membrane assembly defects
(More` et al., 2019). Based on the similar domain organization
of LpoB and LpoP and the observed activation of PaPBP1B,
we hypothesize that LpoP has analogous roles in the
P. aeruginosa pathogen.
We propose that LpoPwould not only act to regulate PaPBP1B
at this broad mechanistic level, but also in a similar way at the
protein level. We observed that LpoP interacts strongly with
the UB2H domain via SPR analysis, and our co-evolutionary
analysis convincingly suggests that this interaction interface is
roughly spatially conserved with that of EcPBP1B-LpoB (Fig-
ure 5). Together with previous data showing that it is possible
to generate hyperactive PBP1Bmutants that do not require acti-
vation by LpoB or LpoP in both species (Greene et al., 2018), this
supports the notion for a commonmechanism for Lpo binding to
conserved regions between the UB2H and GTase domains,
leading to similar conformational rearrangements (Figure 5B).
These conformational rearrangements activate PBP1B in
E. coli (Egan et al., 2014, 2018; Lupoli et al., 2014; Paradis-Bleau
et al., 2010; Typas et al., 2010), and, likewise, we see a similar
activation in the GTase and TPase activity of PaPBP1B by
LpoP, further reinforcing a conserved pathway of conformational
activation.
Figure 3. LpoP Interacts Directly with
PaPBP1B to Activate the Synthase
(A) Representative SPR binding curves resulting
from LpoP or PaCpoB injection over immobilized
PaPBP1B. The concentration of analyte protein
injected is plotted against the response to its
specific binding, or lack thereof, elicited at equi-
librium. The protein injected is indicated next to the
corresponding curve. Non-linear regression
assuming one-site saturation was used to calcu-
late the dissociation constant, KD. The KD shown is
the mean with standard deviation (SD) for n = 4.
(B) Quantification of relative GTase reaction rate
and TPase domain activity (the sum of both pep-
tide crosslinking and carboxypeptidase activity) of
PaPBP1B with and without LpoP and/or PaCpoB.
The data shown are the mean with SD for n = 4 and
3, respectively. Corresponding representative
high-performance liquid chromatography chro-
matograms and GTase data are shown in Fig-
ure S3.
4 Structure 28, 1–8, June 2, 2020
Please cite this article in press as: Caveney et al., Structure of the Peptidoglycan Synthase Activator LpoP in Pseudomonas aeruginosa, Structure
(2020), https://doi.org/10.1016/j.str.2020.03.012
Differences between LpoB- and LpoP-Based Systems
Despite the overarching conserved features between LpoB- and
LpoP-based PBP1B activation mechanisms described above,
there are also key differences. First, the structure of the C-terminal
globular domainof LpoP isdistinct from thatof LpoB. LpoP’sC-ter-
minal globular domain exclusively consists of three repeated TPR
motifs, giving it primarily alpha-helical character and a structure
greatly similar to the N-terminal domain of CpoB (Figures 2C and
S2).This is instarkcontrast to theC-terminaldomainofLpoB,which
consistsofan internal4-strandbsheetflankedbyN-andC-terminal
helices with an overall structural similarity to the N-terminal domain
of TolB (Egan et al., 2014; King et al., 2014) (Figure S2C).
It appears that, despite thestarkdifferencebetween theglobular
domains of LpoBand LpoP, the use of TPRmotifs in the regulation
ofclassAPBPproteins isacommon theme.Wesee theuseofTPR
motifs in both the negative regulator CpoB, as well as in the LpoA
Figure 4. Interaction of LpoP with the
PaUB2H Domain of PaPBP1B
(A) Quantified BLI binding data for biotin-labeled
PaUB2H binding to LpoP.
(B) Region of 1H–15N correlation spectra showing
chemical shift perturbations induced on 15N-
labeled LpoP by addition of different ratios of
PaUB2H. The spectra plotted in black, blue, and
red correspond to a UB2H/LpoP ratio of 0, 1.2, and
1.8, respectively. The samples were prepared with
115 mM of 15N LpoP in 50 mM HEPES buffer (pH
7.0) containing 150 mM NaCl. PaUB2H was
concentrated in the exact same buffer to reach a
final concentration of 150 mM and added to the
NMR tube to obtain the different ratios. The NMR
experiments were recorded at 25C and on a 20-T
NMR spectrometer.
(C) Residues showing a higher perturbation than
0.015 ppm upon UB2H addition are mapped in red
on the surface and cartoon representation of the
LpoP structure.
(D) Sequence conservation scores were calculated
using the ConSurf webserver (Landau et al., 2005)
and displayed on the surface representation of
LpoP using the same orientation as (C). Scores
range from 1 (not conserved, cyan) to 9 (highly
conserved, magenta).
activator of E. coli PBP1A. Interestingly, in
the case of LpoA, these TPR repeats are
seen to be involved in the extension of
Lpo across the periplasm, instead of a
direct interaction module as seen in LpoP
and CpoB. Regardless, it is remarkable
how activators and regulators of class A
PBPs evolved from similar domain pieces
in these distinct lineages.
Beyond the purely structural differ-
ences between the LpoP and LpoB sys-
tems, the different effects of CpoB on the
two activators is of interest. Here, we see
that PaCpoB does not reduce the activa-
tion of the TPase activity of PaPBP1B by
LpoP. This is explained by the lack of an
interaction between PaCpoB and PaPBP1B. In E. coli the cpoB
gene is adjacent to the genes for the Tol-Pal apparatus and
CpoB has been proposed to act as a link between outer mem-
brane constriction and PG synthesis activity. Perhaps CpoB pri-
marily plays a role in the Tol-Pal apparatus, and interaction with
PG synthases evolved downstream in a subset of
Gammaproteobacteria. It will be of interest to further test this hy-
pothesis by determining potential alternate roles for CpoB in
Pseudomonas strains, and if the potential lack of a PG synthase
regulatory function correlates to the presence of an LpoP.
Conclusion
We report the structure and organization of LpoP and its inter-
action site with PBP1B from P. aeruginosa. We highlight the
similarities and key differences between this activator-PG syn-
thase system and the LpoB-based PBP1B activation in E. coli.
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Our data expand upon a semi-conserved mechanism for
PBP1B activation in P. aeruginosa and other LpoP-based sys-
tems first proposed by Greene et al. (2018). Using this knowl-
edge of the specificities of LpoP- and LpoB-based class A
PBP regulation, we hope to inform the future study and poten-
tial inhibition of relevant pseudomonal pathogens. Nosocomial
infections from the latter are a major health burden to immuno-
compromised, AIDS, burn, and cystic fibrosis patients, for
example, and a species-directed antimicrobial to lessen the
long-term respiratory burden inflicted by these strains is direly
needed.
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Figure 5. Interaction between LpoP and
PaPBP1B
(A) A scheme of the domains of PaPBP1B.
(B) The sequence of PaPBP1B with potential inter-
acting residues labeled with an asterisk. Asterisks
denote low to medium confidence (>0.2) proba-
bility scores from GREMLIN co-evolutionary anal-
ysis between LpoP and PaPBP1B.
(C) A schematic representation of the proposed
model for PaPBP1b activation and regulation, in
comparison with EcPBP1b. We propose a folding-
independent activator binding site between the
UB2H and GTase domains in PaPBP1B (i) and the
absence of an interaction between PaCpoB and
PaPBP1B in P. aeruginosa (ii).
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STAR+METHODS
KEY RESOURCES TABLE
REAGENT or RESOURCE SOURCE IDENTIFIER
Bacterial and Virus Strains
BL21 NEB C2527I
Chemicals, Peptides, and Recombinant Proteins
Thrombin Novagen 69671-3
cOmpleteTM EDTA-free protease inhibitor Roche 11873580001
Ni-NTA Qiagen 30210
Ni-NTA Superflow Qiagen 30410
Bocillin ThermoFisher B13233
Deposited Data
CpoB (Krachler et al., 2010) PDB ID: 2XEV
BcsC (Nojima et al., 2017) PDB ID: 5XW7
LpoA (Vijayalakshmi et al., 2008) PDB ID: 3CKM
LpoB (King et al., 2014) PDB ID: 4Q6Z
LpoP this study PDB ID: 6W5Q
Oligonucleotides
pET28 linearization forward primer:
ATGGCTAGCATGACTGGTGGAC
this study n/a
pET28 linearization reverse primer:
ATGGCTGCCGCGCGGCACCAG
this study n/a
PaPBP1B SLIC forward primer:
TGGTGCCGCGCGGCAGCCATATGAC
GCGTCCCCGATCCC
this study n/a
PaPBP1B SLIC reverse primer:
TGTCCACCAGTCATGCTAGCCATTTA
TTCAATTCAGCCAGCCACGTAC
this study n/a
LpoP SLIC forward primer:
CTGGTGCCGCGCGGCAGCCATGC
CAGCCCGCAGCACGGGG
this study n/a
LpoP SLIC reverse primer: TGTC-
CACCAGTCATGCTAGCCATTATCAG
GAGCTGACCTTGGCCT
this study n/a
PaCpoB SLIC forward primer:
CTGGTGCCGCGCGGCAGCCAT
ATGCCCAAGCACCTGCGTGT
this study n/a
PaCpoB SLIC reverse primer: TG
TCCACCAGTCATGCTAGCCATT
TAGCGAAGGTTCTTGAGATCGCGC
this study n/a
Recombinant DNA
pET28a Novagen 69864-3
PaPBP1B Expression this study pAJFE52
LpoP Expression this study pAJFE57
LpoP142-259Expression this study NC_50
PaUB2H Expression this study UB2H_exp
PaCpoB Expression this study pAJFE50
Software and Algorithms
SigmaPlot 13 Systat Software Inc. n/a
(Continued on next page)
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LEAD CONTACT AND MATERIALS AVAILABILITY
Further information and requests for resources should be directed to and will be fulfilled by the Lead Contact, Dr. Jean-Pierre Si-
morre, e-mail: jean-pierre.simorre@ibs.fr). This study did not generate new unique reagents.
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Proteins were recombinantly expressed in the E.coli BL21 (DE3) strain carrying plasmids listed in the Key Resources Table.
METHOD DETAILS
Plasmid Construction
Expression vectors for PaPBP1B (pAJFE52), LpoP lacking its lipoprotein sorting sequence (residues 20-259) (pAJFE57), and PaCpoB
lacking its periplasmic export sequence (residues 22-274) (pAJFE50) have been prepared by Sequence and Ligase Independent
Cloning (SLIC) following the procedure described previously (Jeong et al., 2012). Genes have been inserted into pET28a, which
had been linearized and amplified by PCR, opening the vector at the NdeI restriction site. Resulting proteins possessed an N-terminal
hexa-Histidine tag followed by a thrombin cleavage sequence. pET28 linearization forward primer: ATGGCTAGCATGACTGGTG
GAC. pET28 linearization reverse primer: ATGGCTGCCGCGCGGCACCAG. Gene inserts, with SLIC compatible complementary
overhang sequences for insertion into the linearized pET28, have been amplified from P. aeruginosa PA01 genomic DNA template.
PaPBP1B SLIC forward primer: TGGTGCCGCGCGGCAGCCATATGACGCGTCCCCGATCCC. PaPBP1B SLIC reverse primer:
TGTCCACCAGTCATGCTAGCCATTTATTCAATTCAGCCAGCCACGTAC. LpoP SLIC forward primer: CTGGTGCCGCGCGGCAGC
CATGCCAGCCCGCAGCACGGGG. LpoP SLIC reverse primer: TGTC- CACCAGTCATGCTAGCCATTATCAGGAGCTGACCTT
GGCCT. PaCpoB SLIC forward primer: CTGGTGCCGCGCGGCAGCCATATGCCCAAGCACCTGCGTGT. PaCpoB SLIC reverse
primer: TGTCCACCAGTCATGCTAGCCATTTAGCGAAGGTTCTTGAGATCGCGC.
LpoP Protein Purification
For LpoP purification, pAJFE57 was transformed into BL21(DE3). This strain was cultured in 1.5 L of LB at 30C to an OD578 of 0.5, at
which point 1mM IPTGwas added to induce protein overproduction for 3 h at 30C. The culture was rapidly cooled before harvesting
by centrifugation, cells have been resuspended in 80 mL 25 mM Tris/HCl, 500 mM NaCl, 20 mM imidazole, 10% glycerol, pH 7.5.
Sigma protease inhibitor cocktail (PIC) at 1 in 1000 dilution and 100 mM PMSF have been added to the resuspension before cells
have been disrupted by sonication (Branson digital sonifier). Lysed cells have been fractionated by ultracentrifugation (130,000 x
g, 1 h, 4C). The soluble fraction was applied to a 5 mL HisTrap column attached to an A¨KTA Prime+ equilibrated in resuspension
buffer indicated above. The column was washed with 25 mM Tris/HCl, 1 M NaCl, 40 mM imidazole, 10% glycerol, pH 7.5 before
elution of bound protein with 25 mM Tris/HCl, 500mMNaCl, 400 mM imidazole, 10% glycerol, pH 7.5. His-LpoP containing fractions
have been pooled and 4 U/mL restriction grade thrombin (Novagen) was added. The sample was dialysed against 20 mM Tris/HCl,
200 mMNaCl, 10% glycerol, pH 7.5 for 20 h at 4C. The sample was applied to a size exclusion chromatography column (HiLoad 16/
600 Superdex200 pg) equilibrated in 20mMHEPES/NaOH, 200mMNaCl, 10%glycerol, pH 7.5 attached to an A¨KTA Prime+ system.
The sample was resolved at 0.8 mL/min. Fractions have been collected and concentrated to 4 mL.
Labeled LpoP for NMR Spectroscopy
For LpoP purification, pAJFE57 was transformed into BL21(DE3). This strain was cultured in 1 L of M9 containing 1g/L of ammonium
chloride and 2g/L of glucose at 37C to an OD600nm of 0.6, at which point 1 mM IPTG was added to induce protein overproduction
Continued
REAGENT or RESOURCE SOURCE IDENTIFIER
ForteBio Data Analysis Software ForteBio n/a
XDS (Kabsch, 2010) n/a
Rosetta (Leaver-Fay et al., 2011) n/a
AMPLE (Bibby et al., 2012) n/a
SWISS-MODEL (Waterhouse et al., 2018) n/a
Buccaneer (Cowtan, 2006) n/a
Phenix (Adams et al., 2010) n/a
Coot (Emsley and Cowtan, 2004) n/a
TopSpin Bruker n/a
CcpNmr Analysis Software (Vranken et al., 2005) n/a
GREMLIN (Ovchinnikov et al., 2014) n/a
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for 4 h at 30C. After harvesting, cells have been resuspended in 15 mL 20 mM Tris pH8, 300 mM NaCl buffer supplemented with 1
tablet of cOmpleteTM EDTA-free (Roche) as protease inhibitor cocktail. Cells have been disrupted by sonication (Sonics Vibra
CellTM). Lysed cells have been clarified by centrifugation (46 000 g, 40 min, 4C). The soluble fraction was applied to a 4 mL Ni-
NTA (Qiagen) column beforehand equilibrated in resuspension buffer. After sample application the column was washed with equil-
ibration buffer containing 25 mM imidazole. Elution was performed using the same buffer supplemented with 500 mM imidazole.
Fractions containing the protein have been pooled and injected to a size exclusion chromatography column (HiLoad 26/600 Super-
dex75 pg) equilibrated in 20 mM Tris pH8, 300 mM NaCl buffer. Fractions have been dialysed against 50 mM HEPES pH 7, 150 mM
NaCl buffer for NMR or dialysed against 20 mM Tris, 150 mM NaCl, pH 8 for BLI interactions tests.
LpoP
142-259 Protein Purification
Plasmid expressing LpoP142-259 (NC_50) has been transformed into E. coliBL21(DE3) expression strain. This strain has been cultured
in LB at 37C to an OD600 of 0.6, at which point 1 mM IPTG has been added to induce protein overproduction overnight at 25C. For
purification of LpoP142-259, cell pellets have been resuspended in lysis buffer (20 mM HEPES, pH 8.0, 300 mM NaCl, 10% glycerol)
and lysed by processing twice with a homogenizer (15 kPa; Avestin). Cellular debris was pelleted by centrifugation at 125,000 x g for 1
hour. The resultant supernatant was loaded onto 10 mL Ni2+-saturated Ni-NTA superflow beads (Qiagen), washed with 65 mM imid-
azole in 20 mM HEPES, pH 8.0, 300 mM NaCl, and the protein was eluted with 300 mM imidazole in the previous buffer. 1 U of
thrombin was added per mg of protein to remove the N-terminal His-tag overnight at 4C). Samples have been purified further by
size exclusion chromatography (SEC) with a Superdex 200 column (GE Lifesciences) equilibrated in 20 mM HEPES, pH 8.0,
150 mMNaCl. Fractions containing pure LpoP have been pooled and concentrated to 30 mg/mL. Protein was frozen rapidly in liquid
nitrogen and stored at -80C until required.
PaPBP1B Protein Purification
PaPBP1B was prepared by largely the same procedure as its E. coli homologue, described previously (Bertsche et al., 2006) with
modifications. Plasmid pAJFE52 was transformed into E. coli BL21(DE3) expression strain. This strain was cultured in 1.5 L of LB
at 30C to an OD578 of 0.5, at which point 1 mM IPTG was added to induce protein overproduction for 3 h at 30C. The culture
was rapidly cooled before harvesting by centrifugation, cells have been resuspended in 80 mL 25 mM Tris/HCl, 500 mM NaCl,
1 mM EGTA, 10% glycerol, pH 7.5. Sigma protease inhibitor cocktail (PIC) at 1 in 1000 dilution and 100 mM PMSF have been added
to the resuspension before cells have been disrupted by sonication (Branson digital sonifier). Lysed cells have been fractionated by
ultracentrifugation (130,000 x g, 1 h, 4C). Insoluble material was resuspended in 45 mL 25mM Tris/HCl, 5 mMMgCl2, 1 M NaCl, 20%
glycerol, 2% Triton X-100, pH 7.5 plus 1/1000 PIC and 100 M phenylmethylsulphonylfluoride (PMSF) and mixed overnight at 4C.
Remaining insoluble material was pelleted by a second ultracentrifugation step, leaving solubilised membrane protein in the super-
natant. The sample was diluted 1:1 with 25 mM Tris/HCl, 1 M NaCl, 40 mM imidazole, 20% glycerol, pH 7.5 before application to a
5 mL HisTrap column attached to an A¨KTA Prime+ equilibrated in 25 mM Tris/HCl, 2.5 mMMgCl2, 1 M NaCl, 20 mM imidazole, 20%
glycerol, 1% Triton X-100, pH 7.5. After binding the column was washed with 25 mM Tris/HCl, 1 M NaCl, 50 mM imidazole, 20%
glycerol, 0.2% Triton X-100, pH 7.5 before elution of bound protein with 25 mM Tris/HCl, 1 M NaCl, 400mM imidazole, 20% glycerol,
0.2% Triton X-100, pH 7.5. His-PaPBP1B containing fractions have been pooled and 4 U/mL restriction grade thrombin (Novagen)
was added. The sample was dialysed against 25 mM Tris/HCl, 1 M NaCl, 0.5 mM EGTA, 10% glycerol, pH 7.5 for 20 h at 4C.
The sample was then dialysed against a sequence of buffers in preparation for ion exchange chromatography. Firstly 4 h against
20 mMNaAc, 1 M NaCl, 10% glycerol, pH 5.0, followed by 16 h against 20 mMNaAc, 300 mMNaCl, 10% glycerol, pH 5.0. The sam-
ple was diluted 1:1 with 20 mM NaAc, 50 mM NaCl, 10% glycerol, 0.2% reduced Triton X-100, pH 5.0 before application to an equil-
ibrated 1 mL HiTrap SP column attached to an A¨KTA Prime+ system. The column was equilibrated in buffer A (20 mMNaAc, 200 mM
NaCl, 10% glycerol, 0.2% reduced Triton X-100, pH 5.0). PaPBP1B was eluted by gradient from 100% buffer A to 100% buffer B
(20 mM NaAc, 2 M NaCl, 10% glycerol, 0.2% reduced Triton X-100, pH 5.0) over 14 mL. PaPBP1B containing fractions have been
pooled and dialysed against 20 mM NaAc, 500 mM NaCl, 20% glycerol, 0.2% reduced Triton X-100, pH 5.0. To ensure correct
folding, the protein’s ability to bind to the fluorescent b-lactam Bocillin was assayed as previously described (Egan et al., 2018) (Fig-
ure S3). ). Briefly, Bocillin binding was assessed by incubating 1 mg of protein in 20 mL of 20 mM HEPES/NaOH pH 7.5, 5 mMMgCl2,
150 mMNaCl, 0.05% Triton X-100 with or without 1 mM ampicillin at 37C for 30 min. After which 50 ng of BOCILLINTM FL (Bocillin;
Invitrogen, USA) was added before further incubation at 37C for 30 min. 15 mL of each sample was resolved by SDS-PAGE, the gel
then imaged by Typhoon scanner 9400 with excitation and emission filters of 488 and 520 nm, respectively. The same gel was then
stained using Coomassie Brilliant-Blue.
PaUB2H Domain Purification
Plasmid carrying UB2Hdomain ofPseudomonas aeruginosa PBP1b (UB2H_exp) was transformed in Bl21(DE3) competent cells. This
strain was cultured to an OD600nm of 0.7, at which point 1 mM IPTG was added to induce protein overproduction for 3h at 37
C. After
harvesting cells, pellet was resuspended in 20 mL 50 mM Tris pH 7.5 buffer. Cells have been disrupted by sonication (Sonics Vibra
CellTM) and lysate was centrifuged in a Beckman cold centrifuge (30minutes, 46000g). The supernatant was discarded and inclusion
bodies containing PaUB2H was washed following cellular fractionation protocol alternating four washing steps in different buffer and
centrifugations. The centrifugation steps have been done at 4C during 30 min at 46000g. Washing steps have been done using
20 mL of 50 mM Tris pH 7.5, 2 M NaCl buffer, then 50 mM Tris pH 7.5, 1% Triton X100 buffer, finally two washes of 20mL 50 mM
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Tris pH7.5 . At the end inclusion bodies have been solubilized in 80mL of 50 mM Tris pH 7.5, 6M Guanidium during an overnight in-
cubation. After centrifugation (30 min at 46 000g, 4C) the supernatant was loaded on 4 mL of Ni-NTA (Qiagen) column. Column was
washed with 50mM Tris pH 7.5, 6M guanidium, 25 mM Imidazole buffer, and the protein was eluted with 50mM Tris pH 7.5, 6M gua-
nidium, 500mM imidazole. The protein was refolded performing three baths of dialysis against 100mM sodium acetate pH5 buffer.
After centrifugation the soluble protein was injected to a size exclusion chromatography column (HiLoad 26/600 Superdex75 pg)
equilibrated in 100mM sodium acetate pH 5 buffer. PaUB2H was eluted in a single peak corresponding to a monomer of the protein.
PaCpoB Protein Purification
For PaCpoB purification; protein overproduction, immobilised metal affinity chromatography (IMAC), and size exclusion chromatog-
raphy (SEC) have been performed by the same procedure as for LpoP described above. An additional ion exchange chromatography
step, adapted from (Krachler et al., 2010), was included between IMAC and SEC. Post IMAC, His-PaCpoB containing fractions have
been pooled, 4 U/mL thrombin added, and dialysed against 20 mM Tris/HCl pH 8.0 for 20 h at 4C. Some impurities carried from
IMAC precipitate during this stage, these have been removed after dialysis by centrifugation (4000 g, 15 min, 4C). The sample
was applied to a 5 mL HiTrap SP column attached to an A¨KTA Prime+, equilibrated in buffer A (20 mM Tris/HCl pH 8.0). Bound PaC-
poBwas eluted by gradient from 100%buffer A to 100%buffer B (20mMTris/HCl, 500mMNaCl, pH 8.0) over 50mL. In SEC, PaCpoB
eluted as a single peak, consistent with a trimer, as reported for its E. coli homologue (Krachler et al., 2010).
In vitro Protein Interaction and Activity Assays
Surface plasmon resonance (SPR) experiments have been performed as previously described (Egan et al., 2014) using a BioRad Pro-
teOn XPR36 system and associated software (BioRad) with a GLC amine coupling sensorchip. LpoP and PaCpoB samples have
been prepared for injection over the PaPBP1B surface by 1:1 serial dilution from 10 mM to 19.5 nM. Assays have been performed
at 25C, at a flow rate of 75 mL/min and with an injection time of 5 min. The running buffer consisted of 10 mM Tris/HCl, 150 mM
NaCl, 0.05% Triton X-100, pH 7.5. The dissociation constant (Kd) was calculated by non-linear regression using SigmaPlot 13 soft-
ware (Systat Software Inc.). Continuous fluorescence GTase assays have been performed as described previously (Egan and
Vollmer, 2016) with slight modification. PaPBP1B was assayed at a concentration of 0.5 mM 10 mM LpoP at 37C for 1 h. Time points
have been taken every 1min, instead of every 20 s to reduce photobleaching. Measurement of total PG synthesis activity using radio-
labelled lipid II substrate was also performed as previously described (Biboy et al., 2013) using 0.5M enzymewith 10 mMLpoP, 50 mM
PaCpoB at 37C for 3 h. Total TPase activity was calculated as the percentage of muropeptide products known to be produced by
this domain’s function, including peptide cross-linking and DD-carboxypeptidase activity.
Biolayer Interferometry (Bli) Experiments
Biolayer Interferometry Experiments (BLI) have been recorded on an OctetRED96e (Fortebio) using biotinylated protein attached on
streptavidin tips. For biotinylation of LpoP and PaUB2H, 100mL of protein at 3.3 mg/mL an 5,2 mg/mL respectively for LpoP and
PaUB2H are mixed with 10mL of 1M MES pH 5,5, 2,7mL of Biotin-Hydrasin and 6,7mL of EDC (N-(3-Dimethylaminopropyl)-N0-ethyl-
carbodiimide). The reaction of biotinylation is performed 2h at 22C under agitation. After biotinylation UB2H was dialysed in
50mM MES pH 6.5 and LpoP was dialysed in HBS buffer. Non-biotinylated LpoP and UB2H have been prepared in 50mM MES
pH6.5 buffer at 1,88 mg/mL and 5,37mg /mL respectively. UB2H-Biot (25mg/ml) was immobilised on Streptavidin coated -BLI bio-
sensors to reach about 1 nm immobilisation in HBS-T (10mMHepes pH 7,5,150mMNaCl and 0.02%Tween) Buffer. Tips loadedwith
UB2H have been inserted into different LpoP concentrations (0 to 6mM) in HBS-T Buffer at 23C. Kinetics have been recorded with
1200s for association and 1000sec for dissociation phases, experiments have been reproduced twice with 10mM HCl pulses (3x)
used for regeneration between cycles. Responses at equilibrium of the two series (end of the association phase) have been simul-
taneously fitted with the equation Req= Rmax3concKd3conc by ForteBio data analysis software.
X-ray Crystallography and Structure Determination
P. aeruginosa LpoP protein was crystallized at 20C by sitting drop vapour diffusion using 0.2 mL protein solution (30 mg/mL purified
protein in 20mMHEPES, pH 8.0, 150mMNaCl) and 1 mL of mother liquor (0.1 HEPES pH 7.5, 2.5 M AmSO4, 1%PEG 400, 2.5% 1,2-
butanediol). X-ray diffraction data of LpoP was collected on Advanced Light Source beamline 5.0.2. Diffraction data have been pro-
cessed using XDS (Kabsch, 2010) and the structure was solved by molecular replacement using an ensemble of truncated Rosetta
(Leaver-Fay et al., 2011) refined homologymodels in AMPLE (Bibby et al., 2012) based on amodel fromSWISS-MODEL (Waterhouse
et al., 2018) and PDBID:5XW7 (Nojima et al., 2017). The structure was auto-built using Buccaneer (Cowtan, 2006) and subsequently
refined using Phenix (Adams et al., 2010) and Coot (Emsley and Cowtan, 2004). See Table S1 for data collection and refinement
statistics.
NMR Resonance Assignments
The 2D- and 3D-NMR experiments have been collected on 200 mM 13C,15N-labeled LpoP NMR samples in 30 mM HEPES, 200 mM
KCl buffer at pH 7.5 containing 10%D2O. Backbone resonance assignments have been carried out using a combination of 2D
1H-15N-BEST-TROSY and 3D HN(CO)CACB, iHNCACB, HNCO, HN(CA)CO, H(NCACO)NH. In order to limit the number of overlaps,
BEST-TROSY version of the above listed experiments was used (Brutscher et al., 2015; Solyom et al., 2013). For the assignment of
side-chains aliphatic carbons, 2D 1H-13C-HSQC and 3D (H)C(CO)NH, (H)CCH-TOCSY, and H(C)CH-TOCSY experiments have been
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collected. All spectra have been recorded at 25C using Bruker AVANCE spectrometers operating at 800 and 850 MHz proton fre-
quency equipped with TCI cryoprobes.
The NMR spectra have been processed using the TopSpin software by Bruker in its 3.2 version and have been analyzed using the
CcpNmr Analysis software (Vranken et al., 2005). The 1H chemical shifts have been referenced to the internal standard 4,4-dimethyl-
4-silapentane-1- sulfonic acid (DSS)methyl resonance. 13C and 15N chemical shifts have been referenced indirectly using the IUPAC-
IUB protocol (Markley et al., 1998).
NMR Titration Experiments
Interaction studies have been performed with 13C,15N-labeled LpoP at 115 mMprepared in a buffer containing 50 mMHEPES buffer,
pH 7, 150mMNaCl and 5% (vol/vol) D2O. Unlabelled
PaUB2H have been dialyzed in the same buffer at a concentration of 150 mMand
successively added to the NMR tube to reach the protein-to-protein ratio of 0, 0.6, 1.2 and 1.8. [1H,15N]-BEST-TROSY-HSQC spectra
have been collected at 298K for each protein ratio using Bruker AVANCE spectrometers equipped with a TCI cryoprobe and oper-
ating at 850 MHz proton frequency.
Co-evolutionary Analysis
The Baker lab’s GREMLIN software (Ovchinnikov et al., 2014) was used to probe the interface between LpoP and PaPBP1b. Input
sequences were that of the globular domain of LpoP and all residues of PaPBP1b. E-value cut-offs for both sequences have been
set at 10-2 and the alignments have been run for 8 iterations.
Chemical Shift Perturbation Analysis
Analysis software CcpNmr 2.2 was used to monitor protein chemical shift perturbations for every assigned amide resonance by su-
perimposition of the 15N-BEST-TROSY spectra and automatic peak picking. Chemical shift perturbations (Dd) have been calculated
on a per-residue basis for the highest substrate-to-protein ratio as described previously (Egan et al., 2018).
DATA AND CODE AVAILABILITY
Atomic coordinates for the LpoPmodel have been deposited in the protein data bank with accession code 6W5Q [https://doi.org/10.
2210/pdb6W5Q/pdb].
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